Jesper Grau Eriksen

Professor

Aarhus Universitetshospital
Country flagDenmark

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (11)

Background and purpose: Participation in proton therapy (PT) trials may be affected by structural, clinical, and individual factors, potentially excluding certain patient groups. Such disparities can lead to unequal access to potential research benefits and may limit the generalisability of trial findings. This study aimed to identify factors associated with participation in a Danish randomised controlled trial (RCT) comparing proton versus photon radiotherapy for head and neck cancer. Patients and methods: This national cross-sectional study invited patients with pharyngeal and laryngeal cancer, referred for curative-intent radiotherapy at seven Danish radiotherapy clinics between 2022 and 2025, to complete a survey. Respondents were categorised based on enrollment status in a national RCT comparing proton versus photon radiotherapy. Clinical, demographic, psychosocial, and lifestyle data were collected and linked to clinical registry data. Multiple logistic regression was used to assess exposure variables associated with trial participation. Results: Of 304 respondents, 120 (39%) were enrolled in the RCT. Female gender, older age, greater geographical distance to the PT centre, mobility limitations, lower self-rated health status, and lower ability to actively engage with healthcare providers (Health Literacy Questionnaire scale 6) were significantly associated with lower odds of participation. No significant associations were observed for income, education, marital status, or anxiety. Interpretation: The findings indicate that demographic, geographical, functional, and communication-­related factors may limit participation in PT trials. This highlights the need for interventions that enhance the delivery of trial information, strengthen communication between patients and healthcare professionals, and support informed clinical trial decision-making.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Background Comprehensive cancer care requires effective collaboration by interprofessional healthcare teams. The need to develop educational initiatives to improve interprofessional collaboration is increasingly recognised. However, there is no agreement regarding the interprofessional competencies required for effective cancer care leading to much variation on the focus of research, planning and managing change. A scoping review was conducted to identify the current status of IPE in cancer care and to summarise the results of previous research in order to guide the development of interprofessional education in cancer care. Methods The JBI Scoping Review guidelines were used to guide the process of the review. A search of the available literature was conducted in CINAHL, MEDLINE (Ovid), PubMed, PsycInfo, Scopus databases from January 2012 to March 2023 to investigate IPE for health professional clinicians working in cancer care. Results Of the 825 initial references and 153 studies imported for screening, a total of 28 studies were included in the final review. From those studies, seven focused on the need for IPE and interprofessional competence for oncology healthcare professionals, four reviewed existing IPE programs and 17 described the development and evaluation of interprofessional education. Findings show variation and lack of concept definitions underpinning research in IPE in cancer care settings. Variation also exists in the range of research activities in IPE, most notably related to communication, teamwork and the development of interprofessional practice. The evaluation of impact of IPE is mainly focused on health care professionals’ self-evaluation and general feedback. Impact on patient care was only evaluated in one study. Conclusions Based on the results, interprofessional education research in the field of cancer care is limited in Europe. Thus, there is a significant increase in publications in the last five years. A more systematic focus on the theoretical framework and definition of concepts would be of value. Research and programme development should be based on a shared understanding on what constitutes the interprofessional competences and IPE. Programmes to develop interprofessional practice should be developed and implemented systematically with inclusion of validated assessment methods, and evaluated and improved regularly.

Year:

2024

Objective. Deep learning shows promise in autosegmentation of head and neck cancer (HNC) primary tumours (GTV-T) and nodal metastases (GTV-N). However, errors such as including non-tumour regions or missing nodal metastases still occur. Conventional methods often make overconfident predictions, compromising reliability. Incorporating uncertainty estimation, which provides calibrated confidence intervals can address this issue. Our aim was to investigate the efficacy of various uncertainty estimation methods in improving segmentation reliability. We evaluated their confidence levels in voxel predictions and ability to reveal potential segmentation errors. Approach. We retrospectively collected data from 567 HNC patients with diverse cancer sites and multi-modality images (CT, PET, T1-, and T2-weighted MRI) along with their clinical GTV-T/N delineations. Using the nnUNet 3D segmentation pipeline, we compared seven uncertainty estimation methods, evaluating them based on segmentation accuracy (Dice similarity coefficient, DSC), confidence calibration (Expected Calibration Error, ECE), and their ability to reveal segmentation errors (Uncertainty-Error overlap using DSC, UE-DSC). Main results. Evaluated on the hold-out test dataset ( n = 97), the median DSC scores for GTV-T and GTV-N segmentation across all uncertainty estimation methods had a narrow range, from 0.73 to 0.76 and 0.78 to 0.80, respectively. In contrast, the median ECE exhibited a wider range, from 0.30 to 0.12 for GTV-T and 0.25 to 0.09 for GTV-N. Similarly, the median UE-DSC also ranged broadly, from 0.21 to 0.38 for GTV-T and 0.22 to 0.36 for GTV-N. A probabilistic network—PhiSeg method consistently demonstrated the best performance in terms of ECE and UE-DSC. Significance. Our study highlights the importance of uncertainty estimation in enhancing the reliability of deep learning for autosegmentation of HNC GTV. The results show that while segmentation accuracy can be similar across methods, their reliability, measured by calibration error and uncertainty-error overlap, varies significantly. Used with visualisation maps, these methods may effectively pinpoint uncertainties and potential errors at the voxel level.

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (23)

Christian Maare

consultant oncologist, MD, ph.d., Head and Neck Section

-

DENMARK
View details

Keith Hunter

Chair

University of Liverpool

UNITED KINGDOM
View details

Kenneth Jensen

Aarhus University

DENMARK
View details

Stine Sofia Korreman

Professor

Aarhus University

DENMARK
View details

Jan Alsner

Aarhus University

DENMARK
View details

Wendy McInally

Associate Head of School for Research and Scholarship

Open University

UNITED KINGDOM
View details

Antti A. Mäkitie

Professor and Chair

University of Helsinki

FINLAND
View details

Jørgen Johansen

University of Southern Denmark

DENMARK
View details

Jasper Nijkamp

Associate Professor, Head of Innovation

Aarhus University

DENMARK
View details

Matthias Guckenberger

Chairman

University Hospital of Zurich

SWITZERLAND
View details

Annesofie Lunde Jensen

VIP, Associate Professor

Aarhus University

DENMARK
View details

Christian Rønn Hansen

Asso. Prof

Odense University Hospital

DENMARK
View details

Mererid Evans

Clinical Professor

Cardiff University

UNITED KINGDOM
View details

Hanna Rahbek Mortensen

Associate Professor

Aarhus University

DENMARK
View details

Cai Grau

VIP, Professor

Aarhus University

DENMARK
View details

Jonas Teuwen

-

NETHERLANDS
View details

Jeppe Friborg

Clinical Research Associate Professor

Københavns Universitet

DENMARK
View details

Weronika Maria Szejniuk

Aalborg University

DENMARK
View details

Martin Skovmos Nielsen

Aalborg University

DENMARK
View details

Roberto Maroldi

University of Brescia

ITALY
View details

Susanne Oksbjerg Dalton

Professor, Head of COMPAS Danish Research Center for Equality in Cancer

Zealand University Hospital Køge

DENMARK
View details

Melvin Chua

Professor (with Tenure)

Duke-NUS Medical School

SINGAPORE
View details

Virpi Sulosaari

Executive lecturer, research group leader

University of Turku

FINLAND
View details